This study aimed to analyze the expression of BCL11b and CDKN2A in CD30-positive PTCL and CD30-negative PTCL, in order to guide the pathological classification, prognosis, and clinical treatment of PTCL. Here, BCL11B is linked to mature T-cell and NK-cell non-Hodgkin lymphoma.